| Lauren subtypes of advanced gastric cancer influence survival and response to chemotherapy: real-world data from the AGAMENON National Cancer Registry P Jiménez Fonseca, A Carmona-Bayonas, R Hernández, A Custodio, ... British journal of cancer 117 (6), 775-782, 2017 | 92 | 2017 |
| Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of … A Custodio, A Carmona-Bayonas, P Jiménez-Fonseca, ML Sánchez, ... British Journal of Cancer 116 (12), 1526-1535, 2017 | 54 | 2017 |
| Surgery for metastases for esophageal-gastric cancer in the real world: data from the AGAMENON national registry A Carmona-Bayonas, P Jiménez-Fonseca, I Echavarria, MS Cánovas, ... European Journal of Surgical Oncology 44 (8), 1191-1198, 2018 | 46 | 2018 |
| On the effect of triplet or doublet chemotherapy in advanced gastric cancer: results from a National Cancer Registry A Carmona-Bayonas, P Jiménez-Fonseca, MLS Lorenzo, ... Journal of the National Comprehensive Cancer Network 14 (11), 1379-1388, 2016 | 26 | 2016 |
| Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in first-line treatment of advanced gastric cancer: real-world data from the … A Carmona-Bayonas, P Jiménez-Fonseca, A Custodio, ... Gastric Cancer 21, 96-105, 2018 | 22 | 2018 |
| Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry A Viúdez, A Carmona-Bayonas, J Gallego, A Lacalle, R Hernández, ... Clinical and Translational Oncology 22, 734-750, 2020 | 10 | 2020 |
| Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry F Alvarez-Manceñido, P Jimenez-Fonseca, A Carmona-Bayonas, ... Gastric Cancer 24, 926-936, 2021 | 9 | 2021 |
| External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry P Jimenez-Fonseca, A Carmona-Bayonas, A Martinez-Torron, M Alsina, ... Therapeutic Advances in Medical Oncology 13, 17588359211019672, 2021 | 6 | 2021 |
| First-line triplet or doublet chemotherapy for advanced gastric cancer: Analysis of 970 patients from a community practice registry IE Diaz-Guardamino, A Carmona-Bayonas, PJ Fonseca, AJM Martin, ... Annals of Oncology 27, vi212, 2016 | 3 | 2016 |
| Treatment of advanced gastric cancer based on Lauren’s histological: Real-world data from the AGAMEMON National Cancer Registry A Carmona-Bayonas, P Jiménez-Fonseca, R Hernández, A Custodio, ... Annals of Oncology 28, v231, 2017 | | 2017 |
| Anthracycline-based triplets do not improve the efficacy of platinum-fluoropyrimidine doublets in advanced gastric cancer: AGAMENON study data I Macias, A Carmona-Bayonas, M Ferrer, R Hernandez, A Custodio, ... Annals of Oncology 28, v224, 2017 | | 2017 |
